Apimeds Pharmaceuticals US, Inc. (APUS)

NYSEAMERICAN: APUS · USD

$3.05

+0.00 (0.0%)· Recorded snapshot

Market cap	4.6M
Shares out	1.5M
Volume	63,140

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Market cap: 4.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	보유

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROEn/a

P25 -113.8P50 -46.5P75 -0.9

ROIC-78.6

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

S&P 500+0.5%

Nasdaq Composite-2.4%

Dow Jones Industrial Average+1.8%

Russell 2000+1.8%

All APUS indicators

Market & fundamental data

Available fields

126

Groups with data

Currency

USD

Showing 126 of 126 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001894525
Company name	Apimeds Pharmaceuticals US, Inc.
Country	United States
Country code	US
CUSIP number	03771D201
Earnings date	2026-11-11
Earnings time	amc
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2025-09-30
First seen	2026-05-09
Fiscal year end	December
Founded	2020
Industry	Drug Manufacturers - Specialty & Generic
IPO date	2025-05-09
Is primary listing	Yes
Is SPAC	No
ISIN number	US03771D2018
Last 10-K release date	2026-05-04
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-07-24
Last stock split type	Reverse
Market cap	$4.6M
Market cap category	Nano-Cap
Next earnings date	2026-11-11
Options	No
Price	$3.05
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	APUS
U.S. state	New Jersey
Website	https://www.mindwavedao.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
FCF yield	-120.22%
Industry forward P/E	13.87x
Industry P/E	173.94x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROIC	-78.61%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-35,909
Depreciation and amortization	$1,721
FCF per share	$-3.47
Financing cash flow	$12.2M
Free cash flow	$-5.2M
Free cash flow minus SBC	$-7.2M
Investing cash flow	$-35,909
Net borrowing	$250,100
Net cash flow	$7M
Operating cash flow minus SBC	$-7.1M
Stock-based compensation	$1.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Piotroski F-Score	0
Property, plant and equipment	$34,188

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$9.1M
Current liabilities	$1.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-29.09%
Dividend yield	0%
Shareholder yield	-29.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$8.97
1D price change	0%
1M price change	-58.62%
1M total return	-58.62%
1W price change	-12.02%
1W total return	-12.02%
20-day SMA	$4.23
200-day SMA	$10.95
3M price change	-52.31%
3M total return	-52.31%
50-day SMA	$3.75
50-day SMA vs 200-day SMA	50under200
52-week high	$59.70
52-week high date	2026-05-05
52-week low	$1.51
52-week low date	2026-09-16
6M price change	-84.04%
6M total return	-84.04%
All-time high	$59.70
All-time high date	2026-05-05
All-time low	$1.51
All-time low date	2026-09-16
Average true range (ATR)	$0.92
Average volume	5.2M
Beta (1Y)	3.28
Change from 52-week high	-94.89%
Change from 52-week low	101.99%
Change from all-time high	-94.97%
Change from all-time low	98.68%
Change from open	1.67%
Day's gap	-1.64%
Dollar volume	$192,577
High price	$3.05
Low price	$2.87
Monthly RSI	0
Open price	$3.00
Position in 52-week range	100%
Premarket change	-3.28%
Premarket close	$3.05
Premarket price	$2.95
Premarket volume	1K
Previous close	$3.05
Price vs 150-day SMA	-66.54%
Price vs 20-day SMA	-29.08%
Price vs 200-day SMA	-72.6%
Price vs 50-day SMA	-19.94%
Relative volume	0.01
Return from IPO price	-27.75%
RSI	42.06
Sharpe ratio	-0.18
Sortino ratio	-0.3
Volume	63.1K
Weekly RSI	38.83
YTD price change	-81.71%
YTD total return	-81.71%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	725.9K
Float percentage	48.1%
Shares held by insiders	9.38%
Shares held by institutions	2.82%
Shares outstanding	1.5M
Short % of float	10.96%
Short % of shares	5.27%
Short ratio	0 days

Deeper analysis on APUS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this APUS report

Is a complete APUS research report available?

No complete published report is available for Apimeds Pharmaceuticals US, Inc. (APUS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Apimeds Pharmaceuticals US, Inc. (APUS)

Price

Financial snapshot

Fair-value bridge

Latest news · APUS

Valuation

Profitability

Trading

Next earnings

Sector percentile context

All APUS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on APUS

Frequently asked questions